• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植动脉硬化中免疫介导的血管损伤与功能障碍

Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis.

作者信息

von Rossum Anna, Laher Ismail, Choy Jonathan C

机构信息

Department of Molecular Biology and Biochemistry, Simon Fraser University , Burnaby, BC , Canada.

Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia , Vancouver, BC , Canada.

出版信息

Front Immunol. 2015 Jan 12;5:684. doi: 10.3389/fimmu.2014.00684. eCollection 2014.

DOI:10.3389/fimmu.2014.00684
PMID:25628623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4290675/
Abstract

Solid organ transplantation is the only treatment for end-stage organ failure but this life-saving procedure is limited by immune-mediated rejection of most grafts. Blood vessels within transplanted organs are targeted by the immune system and the resultant vascular damage is a main contributor to acute and chronic graft failure. The vasculature is a unique tissue with specific immunological properties. This review discusses the interactions of the immune system with blood vessels in transplanted organs and how these interactions lead to the development of transplant arteriosclerosis, a leading cause of heart transplant failure.

摘要

实体器官移植是终末期器官衰竭的唯一治疗方法,但这种挽救生命的手术受到大多数移植物免疫介导排斥反应的限制。移植器官内的血管是免疫系统的攻击目标,由此产生的血管损伤是急性和慢性移植物衰竭的主要原因。脉管系统是一种具有特定免疫学特性的独特组织。本文综述了免疫系统与移植器官血管之间的相互作用,以及这些相互作用如何导致移植动脉硬化的发生,而移植动脉硬化是心脏移植失败的主要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/4290675/94389429746e/fimmu-05-00684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/4290675/38266ad5611b/fimmu-05-00684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/4290675/94389429746e/fimmu-05-00684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/4290675/38266ad5611b/fimmu-05-00684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/4290675/94389429746e/fimmu-05-00684-g002.jpg

相似文献

1
Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis.移植动脉硬化中免疫介导的血管损伤与功能障碍
Front Immunol. 2015 Jan 12;5:684. doi: 10.3389/fimmu.2014.00684. eCollection 2014.
2
Prevention of chronic rejection and graft arteriosclerosis by tolerance induction.通过诱导耐受预防慢性排斥反应和移植血管硬化。
Transplantation. 1995 Jan 27;59(2):282-8.
3
Chronic transplant dysfunction and transplant arteriosclerosis: new insights into underlying mechanisms.慢性移植功能障碍与移植动脉硬化:对潜在机制的新见解
Expert Rev Mol Med. 2003 Jan 13;5(2):1-23. doi: 10.1017/S146239940300557X.
4
Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis.心脏移植受者的加速性动脉粥样硬化与T淋巴细胞介导的内皮炎有关。
Am J Pathol. 1990 Oct;137(4):871-82.
5
Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.移植小鼠心脏中T细胞介导损伤后的冠状动脉粥样硬化:γ干扰素的作用
Am J Pathol. 1998 May;152(5):1187-97.
6
Roles of toll-like receptors signaling in organ transplantation.Toll样受体信号通路在器官移植中的作用。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Dec;36(12):1125-33. doi: 10.3969/j.issn.1672-7347.2011.12.001.
7
Investigation into the onset and progression of transplant arteriosclerosis in a mice aortic retransplantation model.小鼠主动脉再移植模型中移植动脉硬化的发病及进展研究。
Microsurgery. 2008;28(3):182-6. doi: 10.1002/micr.20477.
8
Xenotransplantation: state of the art.异种移植:当前技术水平
Forum (Genova). 1999 Jul-Dec;9(3 Suppl 3):74-83.
9
Metabolic factors and outcome of organ transplantation.代谢因素与器官移植的结果
Scand J Urol Nephrol Suppl. 1994;159:1-74.
10
Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.罗格列酮可减轻大鼠同种异体主动脉移植后的移植动脉硬化。
Transplantation. 2007 Aug 27;84(4):517-26. doi: 10.1097/01.tp.0000276983.91892.99.

引用本文的文献

1
Dysfunction of Microcirculation in Atherosclerosis: Implications of Nitric Oxide, Oxidative Stress, and Inflammation.动脉粥样硬化中的微循环功能障碍:一氧化氮、氧化应激和炎症的影响
Int J Mol Sci. 2025 Jul 4;26(13):6467. doi: 10.3390/ijms26136467.
2
An agent-based model of cardiac allograft vasculopathy: toward a better understanding of chronic rejection dynamics.基于代理的心脏移植血管病变模型:旨在更好地理解慢性排斥反应动态。
Front Bioeng Biotechnol. 2023 Sep 12;11:1190409. doi: 10.3389/fbioe.2023.1190409. eCollection 2023.
3
RNAseq profiling of blood from patients with coronary artery disease: Signature of a T cell imbalance.

本文引用的文献

1
T follicular helper cell differentiation, function, and roles in disease.T滤泡辅助细胞的分化、功能及其在疾病中的作用。
Immunity. 2014 Oct 16;41(4):529-42. doi: 10.1016/j.immuni.2014.10.004.
2
IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells.白细胞介素-33是一种非常规警报素,可刺激树突状细胞分泌白细胞介素-2,以选择性地扩增白细胞介素-33受体/ST2阳性调节性T细胞。
J Immunol. 2014 Oct 15;193(8):4010-20. doi: 10.4049/jimmunol.1400481. Epub 2014 Sep 12.
3
HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs.
冠心病患者血液的RNA测序分析:T细胞失衡特征
J Mol Cell Cardiol Plus. 2023 Jun;4. doi: 10.1016/j.jmccpl.2023.100033. Epub 2023 Mar 25.
4
Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical -Pro-Arteriosclerotic Inflammatory Response.血清成纤维细胞生长因子 23(FGF-23)在择期心脏手术后持续升高,核因子 κB 受体激活剂配体(RANKL)和软骨寡聚基质蛋白(COMP)是围手术期促动脉粥样硬化炎症反应的一部分。
Med Sci Monit. 2023 Jan 13;29:e937934. doi: 10.12659/MSM.937934.
5
Concomitant elevated serum levels of tenascin, MMP-9 and YKL-40, suggest ongoing remodeling of the heart up to 3 months after cardiac surgery after normalization of the revascularization markers.在心脏血运重建标志物恢复正常后,在心脏手术后 3 个月内,血清中 tenascin、MMP-9 和 YKL-40 水平持续升高,提示心脏持续重构。
Eur J Med Res. 2022 Oct 21;27(1):208. doi: 10.1186/s40001-022-00831-8.
6
RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance.冠心病患者血液中的 RNA 测序:调节性 T 细胞失衡的参与。
BMC Med Genomics. 2021 Sep 3;14(1):216. doi: 10.1186/s12920-021-01062-2.
7
miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy.微小RNA-21拮抗作用可重塑巨噬细胞代谢并消除慢性同种异体移植血管病。
Am J Transplant. 2021 Oct;21(10):3280-3295. doi: 10.1111/ajt.16581. Epub 2021 May 3.
8
Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society.炎症的血管后果:ESH血管结构与功能工作组及动脉协会的立场声明
J Hypertens. 2020 Sep;38(9):1682-1698. doi: 10.1097/HJH.0000000000002508.
9
Triptolide Attenuates Transplant Vasculopathy Through Multiple Pathways.雷公藤红素通过多种途径减轻移植性血管病变。
Front Immunol. 2020 Apr 21;11:612. doi: 10.3389/fimmu.2020.00612. eCollection 2020.
10
The differentiation of mesenchymal stem cells to vascular cells regulated by the HMGB1/RAGE axis: its application in cell therapy for transplant arteriosclerosis.HMGB1/RAGE 轴调控间充质干细胞向血管细胞的分化:在移植性动脉硬化细胞治疗中的应用。
Stem Cell Res Ther. 2018 Apr 3;9(1):85. doi: 10.1186/s13287-018-0827-z.
高迁移率族蛋白B1(HMGB1)通过促进炎症样髓样树突状细胞(mDCs)参与心脏同种异体移植的慢性排斥反应。
Am J Transplant. 2014 Aug;14(8):1765-77. doi: 10.1111/ajt.12781. Epub 2014 Jul 1.
4
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.在无维持性免疫抑制的情况下,联合 HLA 错配的肾和骨髓移植受者的长期结果。
Am J Transplant. 2014 Jul;14(7):1599-611. doi: 10.1111/ajt.12731. Epub 2014 Jun 5.
5
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.使用贝拉西普进行肾移植,无需维持使用类固醇或钙调神经磷酸酶抑制剂。
Am J Transplant. 2014 May;14(5):1142-51. doi: 10.1111/ajt.12712. Epub 2014 Mar 31.
6
Diagnosis and management of antibody-mediated rejection: current status and novel approaches.抗体介导性排斥反应的诊断与管理:现状与新方法
Am J Transplant. 2014 Feb;14(2):255-71. doi: 10.1111/ajt.12589. Epub 2014 Jan 8.
7
Intraplaque hemorrhage in cardiac allograft vasculopathy.心脏移植血管病中的斑块内出血。
Am J Transplant. 2014 Jan;14(1):184-92. doi: 10.1111/ajt.12517. Epub 2013 Dec 4.
8
Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.抗体介导的移植物损伤:补体依赖性和补体非依赖性机制。
Curr Opin Organ Transplant. 2014 Feb;19(1):33-40. doi: 10.1097/MOT.0000000000000040.
9
Immune mechanisms in medium and large-vessel vasculitis.中等和大血管血管炎的免疫机制。
Nat Rev Rheumatol. 2013 Dec;9(12):731-40. doi: 10.1038/nrrheum.2013.161. Epub 2013 Nov 5.
10
Complement-binding anti-HLA antibodies and kidney-allograft survival.补体结合抗 HLA 抗体与肾移植存活。
N Engl J Med. 2013 Sep 26;369(13):1215-26. doi: 10.1056/NEJMoa1302506.